Implementing regulatory flexibilities to enhance compliance and patient access : a practice-based initiative

Abstract

Background: Regulatory frameworks serve an essential role to safeguard public health, notwithstanding this, they may hinder timely access to pharmaceutical care and create additional administrative burden for pharmacists. During routine inspections of community and hospital pharmacies in Malta, several recurring operational challenges were identified that contributed to inefficiencies in service delivery and documentation processes. In response, the Malta Medicines Authority (MMA) sought to introduce proportionate regulatory flexibilities that maintained compliance while supporting pharmacists in delivering efficient and patient‑centred services. The aim of this study is to develop, validate and implement regulatory flexibilities which may reduce administrative burden for pharmacists and improve timely access to pharmaceutical care. Method: Regulatory flexibilities were identified through a combined approach involving a review of relevant legislation, regulatory guidance and international best practices, together with insights gathered during routine pharmacy inspections conducted by MMA inspectors. A focus group discussion consisting of a Pharmacist, Pharmacy Inspector, Senior head of pharmacy inspections and the director was held to assess regulatory soundness, risk implications, feasibility of implementation and to evaluate their potential impact on patient safety, compliance and operational efficiency. Regulatory flexibilities demonstrated through evaluation to yield a positive impact were formally adopted and incorporated into subsequent inspection cycles. Implementation was monitored through inspectors’ feedback, follow‑up inspections and ongoing communication with pharmacists to ensure consistency, clarity and continued adherence to regulatory standards. Results: Five (5) regulatory flexibilities were implemented to streamline processes and support pharmacists in meeting compliance requirements. First, the use of online sources in place of printed physical copies was permitted, enabling timely access to up-to-date reference information and reducing the need for maintaining extensive printed materials. Second, statutory registers were allowed to be stored in secure online formats, improving accessibility, reducing physical storage demands and supporting more efficient record management. Third, a standardised process for the disposal of Dangerous Drug of Abuse (DDAs) was developed to ensure safe and consistent handling of DDAs across pharmacy settings. Fourth, the use of photographs of prescriptions for the daily register was authorised, allowing accurate documentation while reducing administrative workload and minimising transcription errors. Finally, the storage of medicinal products within doctors’ clinics was permitted, if products were kept under lock and key and secured from unauthorised access. Collectively, these flexibilities reduced administrative burden and improved workflow efficiency. Inspectors reported fewer recurrent non‑compliances and pharmacists noted improved practicality in meeting regulatory expectations. No safety concerns or adverse regulatory outcomes were observed following implementation. Conclusion: The introduction of targeted regulatory flexibilities demonstrated that regulatory systems may remain robust while adapting to operational realities in pharmacy practice. These measures supported improved compliance, reduced bureaucratic burden and facilitated more efficient patient access to pharmaceutical care. Continued evaluation will assess the long‑term impact of these flexibilities and identify further opportunities to optimise regulatory processes within the regulatory framework.